Cerevel Therapeutics: Funding, Investors & Team (Oct 2026)
Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson’s disease and substance use disorder.
Cerevel Therapeutics has raised $300M across 1 funding round on record, the most recent a Post-IPO Debt of $300M announced in Aug 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cerevel Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Cerevel Therapeutics Funding Rounds
Cerevel Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Cerevel Therapeutics Funding Compared to Other Biotechnology Startups
Cerevel Therapeutics' latest round of $300M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cerevel Therapeutics in Biotechnology and Boston
Companies Similar to Cerevel Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Cerevel Therapeutics Funding FAQs
What does Cerevel Therapeutics do?
Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson’s disease and substance use disorder.
How much funding has Cerevel Therapeutics raised?
Cerevel Therapeutics has raised $300M across 1 round on record. The most recent is a Post-IPO Debt of $300M announced in Aug 2022.
When did Cerevel Therapeutics last raise funding?
Cerevel Therapeutics' most recent funding round on record is a Post-IPO Debt of $300M, announced in Aug 2022.
Who is the CEO of Cerevel Therapeutics?
Tony Coles is listed as CEO at Cerevel Therapeutics.
Where is Cerevel Therapeutics headquartered?
Cerevel Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Cerevel Therapeutics have?
Cerevel Therapeutics is in the 251-500 employee band.
How does Cerevel Therapeutics' funding compare to other Biotechnology startups?
Cerevel Therapeutics' latest round of $300M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cerevel Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cerevel Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.